1. Jeff Blankley MRPharmS Chair Birmingham Local Pharmaceutical Committee
Value-based Decision Making in Community Pharmacy Funding Cuts and Quality Payments – Session 2
Jeff Blankley MRPharmS
Chair
Birmingham Local Pharmaceutical Committee
Wolverhampton Local Pharmaceutical Committee
Jan 2017
Intro
Seen the style of slides before
Thank to previous presenter
For contractors there are decisions to be made as the business’s profit will come under pressure
And this starts from Dec 16

2. Value-based Decision Making in Community Pharmacy Funding Cuts and Quality Payments – Session 2
Embed Sat’s video here
Welcome
Domestics
Fire
Toilets
Breaks

3. Value-based Decision Making in Community Pharmacy Objectives of Session 2
Recap of cuts and changes to the funding structure
Reminder of Gateway Criteria
Role Clarification
Provide information which enables compliance to claim Quality Payments in
Safeguarding
Dementia Friends
HLP (requirements and training dates)
Clinical Effectiveness
Patient safety and service
Sharing the plan for Feb – Apr 2017
Gather some feedback

4. Value-based Decision Making in Community Pharmacy My Expectations
Pre –work completed (CPPE & Near Miss Log)
You all receive a set of handouts
Phones OFF
We Keep to time
Big room. A lot of people. ONE meeting
That may mean your question is not asked
Car park

5. Value-based Decision Making in Community Pharmacy Supporting YOU to be ready. Usual disclaimer/conditions apply
Summary of Changes
2-year package
-£113m in 16/17 (4 months)
17/18 squeeze to make up the lower reduction in 16/17 (late implementation)
Single Activity Fee (SAF) £1.13 from Dec 16 increasing to £1.24 in April 17
Reduction in Establishment Payment (-20%) in Dec 16 and a further -20% from Apr 17
Introduction of Quality Payments from Apr 17 (£75m) (from existing funding)
Gateway criteria to become eligible for Quality Payments
Introduction of Pharmacy Access Scheme (PhAS) (4 in Birmingham, 1 in Wolverhampton)
Introduction of ERMS linked to NHS 111 (Pilot) (£2m in 16/17) (WIGIG) (PhIF)
Changes to market entry regulations. Mergers, PNAs
Information is right at a certain point in time…….and new information is being received regularly

6. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Total of 100 points
£64 per point
= £6,400 per contract
Size of the prize Birmingham = £1.862m
Size of the prize Wolverhampton = £448k
Could increase as additional allocation if less than 100% uptake
To a max of £128 per point

7. Value-based Decision Making in Community Pharmacy Gateway Criteria for Quality Payments in 17/18
EPS is active and used
NHS Choices is up to date and maintained
Active NHS Mail address and active
Delivery of at least ONE specified Advanced service

8. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Role LPC
Committed to enabling 100% of contractors to claim maximum points
Providing own sessions F2F and sequential written updates
Providing online links and all F2F materials CPWM Website
Signposting local alternatives
Signposting essential allied events
Role of the Contractors
Committed to claiming maximum points
Completing actions on time
Could do with a link to CPWM and a screen shot of the site

9. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Domain
Criteria
Number of review points at which it can be claimed
Points at any one review point
Total points over the two review points
Planned Support
Patient Safety
80% of registered pharmacy professionals have achieved level 2 safeguarding status for children and vulnerable adults within the last two years
Two 5 10
Session 2
Workforce
80% of all pharmacy staff working in patient facing roles are trained ‘Dementia Friends’
Session 2 and others

10. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Domain
Criteria
Number of review points at which it can be claimed
Points at any one review point
Total points over the two review points
Planned Support
Patient Safety
Production of a written report that demonstrates evidence of analysis, learning and action taken in response to near misses and patient safety incidents, including implementation of national patient safety alerts and having shared learning
One 20
Session 2
Patient Experience
Results of patient experience survey from the last 12 months published on the pharmacy’s NHS Choices page 5

11. Session 2 plus additional specific dates
Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Domain
Criteria
Number of review points at which it can be claimed
Points at any one review point
Total points over the two review points
Planned Support
Clinical Effectiveness
Asthma patients dispensed more than 6 short acting bronchodilator inhalers without any corticosteroid inhaler within a 6-month period are referred to an appropriate health care professional for an asthma review
Two 10 20
Session 2
Public Health
Healthy Living Pharmacy level 1 (self-assessment)
One
Session 2 plus additional specific dates

12. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Agenda
10.00 – 12.30
Name Qualification CPPE
Safeguarding & Dementia Friends
12.30 – Lunch
13.15 – 15.00
Leyla Hunnbeck NPA
HLP & Clinical Effectiveness
15.00 – Tea
15.15 – 17.00
Surinderpal Virdee MRPharmS Clinical Governance Pharmacist
Error, near misses & CPPQ

13. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
For CPPE
Jeff Blankley MRPharmS
Chair
Birmingham Local Pharmaceutical Committee
Wolverhampton Local Pharmaceutical Committee
Jan 2017

14. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Insert CPPE slides

15. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Lunch
Back at pm prompt please

16. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Sat’s video again
For 13.15

17. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
For Leyla
Jeff Blankley MRPharmS
Chair
Birmingham Local Pharmaceutical Committee
Wolverhampton Local Pharmaceutical Committee
Jan 2017

18. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Insert NPA slides

19. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
For Surinderpal
Jeff Blankley MRPharmS
Chair
Birmingham Local Pharmaceutical Committee
Wolverhampton Local Pharmaceutical Committee
Jan 2017

20. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Insert Surinder’s slides

21. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18
Thanks to the presenters

22. Value-based Decision Making in Community Pharmacy Quality Payments in 17/18 – Planned Events
Nov
Dec
Jan-17
Feb-17
Mar-17
Session 1
7th or 8th
Session 2
8th All Day
Session 3
tbc
Session 4

23. Value-based Decision Making in Community Pharmacy Handout available To make sure the evidence is gathered BEFORE the event / end of year
Agree the content

24. Quality Payment – Gateway
Value-based Decision Making in Community Pharmacy February Venue tbc Evening
Quality Payment – Gateway
NHS Mail
NHS Choices
Qualification Points
Domain
Criteria
Number of review points at which it can be claimed
Points at any one review point
Total points over the two review points
Digital
Demonstration of having accessed the Summary Care Record and increase in access since the last review point
Two 5 10
Session 3
NHS111 Directory of Services entry up to date at review point
2.5

25. Bringing It All Together PharmOutcomes
Value-based Decision Making in Community Pharmacy March Venue tbc Evening
Bringing It All Together
PharmOutcomes

26. Value-based Decision Making in Community Pharmacy Close
Request feedback form
Don’t forget CPWM Website
Thank you
Safe journey home